Clinical Trial Detail

NCT ID NCT01212822
Title Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

esophageal carcinoma

gastric cardia carcinoma

gastroesophageal junction adenocarcinoma

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult

No variant requirements are available.